CUFinder

Carlo Giannangelo

About Carlo Giannangelo

Carlo Giannangelo, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at Monash University, specializes in the field of Malaria, Parasitology, Systems pharmacology, Metabolomics, Drug mechanisms.

His recent articles reflect a diverse array of research interests and contributions to the field:

Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy

Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action

On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.

Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

Dimeric artesunate glycerophosphocholine conjugate nano-assemblies as slow-release antimalarials to overcome Kelch 13 mutant artemisinin resistance

Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells

System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion

Carlo Giannangelo Information

University

Position

Monash University

Citations(all)

211

Citations(since 2020)

187

Cited By

74

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Carlo Giannangelo Skills & Research Interests

Malaria

Parasitology

Systems pharmacology

Metabolomics

Drug mechanisms

Top articles of Carlo Giannangelo

Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy

2023/8/17

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

Chaille Webb
Chaille Webb

H-Index: 14

Nyssa Drinkwater
Nyssa Drinkwater

H-Index: 12

Peter Scammells
Peter Scammells

H-Index: 32

Sheena Mcgowan
Sheena Mcgowan

H-Index: 22

Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action

2023

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.

bioRxiv

2023

Grennady Wirjanata
Grennady Wirjanata

H-Index: 14

Nyssa Drinkwater
Nyssa Drinkwater

H-Index: 12

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

Tania F De Koning-Ward
Tania F De Koning-Ward

H-Index: 27

Sheena Mcgowan
Sheena Mcgowan

H-Index: 22

Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

Science

2022/6/3

Shuai Nie
Shuai Nie

H-Index: 15

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

David L Gillett
David L Gillett

H-Index: 5

Sumanta Dey
Sumanta Dey

H-Index: 15

William Newman
William Newman

H-Index: 47

Jake Baum
Jake Baum

H-Index: 35

Sabine Ottilie
Sabine Ottilie

H-Index: 13

Dimeric artesunate glycerophosphocholine conjugate nano-assemblies as slow-release antimalarials to overcome Kelch 13 mutant artemisinin resistance

Antimicrobial Agents and Chemotherapy

2022/5/17

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

Wei He
Wei He

H-Index: 23

Tuo Yang
Tuo Yang

H-Index: 14

Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells

ACS infectious diseases

2022/1/5

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

Jianbo Wu
Jianbo Wu

H-Index: 38

Xiaofang Wang
Xiaofang Wang

H-Index: 5

Katja Becker
Katja Becker

H-Index: 33

System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion

PLoS Pathogens

2020/6/26

Carlo Giannangelo
Carlo Giannangelo

H-Index: 4

See List of Professors in Carlo Giannangelo University(Monash University)